A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research-Reference-Cited by-同舟云学术

A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research

Published:2024-02 Issue:2 Volume:23 Page:178-190
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Simuni Tanya,Chahine Lana M,Poston Kathleen,Brumm Michael,Buracchio Teresa,Campbell Michelle,Chowdhury Sohini,Coffey Christopher,Concha-Marambio Luis,Dam Tien,DiBiaso Peter,Foroud Tatiana,Frasier Mark,Gochanour Caroline,Jennings Danna,Kieburtz Karl,Kopil Catherine M,Merchant Kalpana,Mollenhauer Brit,Montine Thomas,Nudelman Kelly,Pagano Gennaro,Seibyl John,Sherer Todd,Singleton Andrew,Stephenson Diane,Stern Matthew,Soto Claudio,Tanner Caroline M,Tolosa Eduardo,Weintraub Daniel,Xiao Yuge,Siderowf Andrew,Dunn Billy,Marek Kenneth

Funder

Lewy Body Dementia Association

Parkinson's UK

Parkinson Society Canada

Michael J Fox Foundation for Parkinson's Research

Cure Parkinson's

Publisher

Elsevier BV

Reference99 articles.

1. Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies;Fairfoul;Ann Clin Transl Neurol,2016

2. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using the α-synuclein seed amplification assay: a cross-sectional study;Siderowf;Lancet Neurol,2023

3. α-synuclein seed amplification assays for diagnosing synucleinopathies: the way forward;Bellomo;Neurology,2022